Table 4 MBL2 haplotypes (promoter region and exon1) and risk assessment
Haplotypes | BWF, n (%) | UM, n (%) | Total n (%) | p |
|---|---|---|---|---|
High MBL expression | ||||
MBL2*LYQA (Y16576) | 20 (46.1) | 24 (39.5) | 54 (41.9) | -NS |
MBL2*HYPA (Y16581) | 6 (14) | 11 (12.8) | 17 (13.2) | NS |
MBL2*LYPA (Y16577) | 3 (7.0) | 2 (2.3) | 5 (3.9) | NS |
Low MBL expression | ||||
MBL2*HYPB | 0 (0.0) | 1 (1.2) | 1 (0.8) | NS |
MBL2*HYPC | 1 (2.3) | 1 (1.2) | 2 (1.5) | NS |
MBL2*LYQC (Y16578) | 5 (11.6) | 20 (23.3) | 25 (19.4) | NS |
MBL2*LYPC | 0 (0.0) | 1 (1.2) | 1 (0.8) | NS |
MBL2*LYPB (Y16579) | 1 (2.3) | 3 (3.5) | 4 (3.1) | NS |
MBL2*LXPA | 7 (16.3) | 13 (15.1) | 20 (15.5) | NS |
Total | 43 (100) | 86 (100) | 129 (100) | |